Oxford BioMedica PLC
LSE:OXB
Oxford BioMedica PLC
Inventory
Oxford BioMedica PLC
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Oxford BioMedica PLC
LSE:OXB
|
Inventory
£15.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
37%
|
CAGR 10-Years
23%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Inventory
£6.7m
|
CAGR 3-Years
96%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Compass Pathways PLC
NASDAQ:CMPS
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Inventory
£74.2m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
16%
|
CAGR 10-Years
8%
|
|
|
Niox Group PLC
LSE:NIOX
|
Inventory
£4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
4%
|
|
Oxford BioMedica PLC
Glance View
Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The company is headquartered in Oxford, Oxfordshire. The firm and its subsidiaries have developed lentiviral vector delivery system, LentiVector platform, which the Company leverages to develop in vivo and ex vivo products both in-house and with partners. Its LentiVector delivery platform has created a portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology, central nervous system (CNS) disorders and liver diseases. The firm's product pipeline includes OXB-302, OXB-203, OXB-204 and OXB-103 and OXB-401. The firm has also developed partnership with various pharmaceutical companies to develop potential gene and cell therapy products. Its partnered products include AXO-LENTI-PD, SAR 422459 and SAR421869.
See Also
What is Oxford BioMedica PLC's Inventory?
Inventory
15.6m
GBP
Based on the financial report for Jun 30, 2025, Oxford BioMedica PLC's Inventory amounts to 15.6m GBP.
What is Oxford BioMedica PLC's Inventory growth rate?
Inventory CAGR 10Y
23%
Over the last year, the Inventory growth was -6%. The average annual Inventory growth rates for Oxford BioMedica PLC have been 4% over the past three years , 37% over the past five years , and 23% over the past ten years .
